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MinireviewAt the Innate Frontiers between
Mother and Fetus: Linking Abortion
with Complement Activation
On the contrary, experimental evidence in mice indi-
cates that fetal alloantigens are indeed recognized by
the maternal adaptive immune system during normal
pregnancy, but this recognition induces a state of toler-
ance in specific maternal T or B cells, as demonstrated
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The weight of experimental evidence supports instead2 University of Paris 7
a role for nonadaptive events taking place just beforePasteur Institute
or during abortion, such as local inflammation and localUnite´ de Biologie Mole´culaire du Ge`ne
hemorrhaging, which are associated in most cases withINSERM U277
complement activation and infiltration by leukocytes—75724 Paris cedex 15
not lymphocytes. Complement activation, a componentFrance
of the inflammatory response, attracts phagocytic cells
to the site and leads to tissue necrosis. Their rapid induc-
tion and lack of specificity and memory suggest thatThe intricate mechanisms regulating fetomaternal in-
these events are part of innate immune responses. Clini-teractions are still largely uncharacterized. Recent pa-
cally, these responses could be triggered by local ne-pers have revealed a major role for the innate immune
crotic lesions (due to stress or ischemia) or infectionssystem during abortion. Different experimental condi-
of the placenta.tions—deletion of a complement regulator, injection
Primordial Role for Complement Regulationof anti-phospholipid antibodies into mothers, or allo-
A growing body of data from experimental modelsrecognition of fetuses in the presence of an IDO inhibi-
strongly reinforces the view that abortions are triggeredtor—all lead to complement activation, inflammation,
when innate immune responses or their regulators areand fetal loss. These observations also raise new
perturbed (Moffett-King, 2002). Thus, the placenta, likequestions on the relationship between the adaptive
all plasma-exposed surfaces of the body, is subjectedand innate systems during pregnancy.
to a low level of complement activation during normal
pregnancy (Morgan and Holmes, 2000), but complementUnderstanding the intricate mechanisms of fetomater-
regulatory proteins are thought to prevent harmful am-nal interactions in placental mammals has remained a
plification of complement activation in successful preg-challenging goal for biologists for decades (Medawar,
nancies.1953). The mother’s immune system faces the double
Complement participates in innate immune responsestask of protecting the mother and the fetus against
by directly lysing cells via the membrane attack complexpathogens or altered cells, as well as preventing the
(MAC) and inducing the recruitment and activation ofrejection of the semi-allogeneic feto-placental unit. Both
inflammatory cells. Complement can attack self tissueevents must take place at the same time. Even though
undergoing inflammation, but cells are normally pro-the peculiar immune status of pregnancy is transient, it
tected against complement attack by proteins that regu-is likely to happen repeatedly in the same individual,
late complement activation, such as decay accelerating
possibly presenting the same paternal alloantigens sev-
factor (DAF/CD55), membrane cofactor protein (MCP/
eral times and thus potentially triggering immune
CD46), and complement receptor 1-related gene/protein
memory. y (Crry). Crry is a membrane-bound protein, structurally
Much insight has been gained in recent years on the similar to MCP and DAF, that inhibits the deposition of
interactions between the innate and adaptive immune activated C3 and C4 on the surface of autologous cells
systems and their responses to foreign antigens. In par- and is expressed in trophoblasts and maternal decidual
allel, the availability and use of genetically engineered tissues in mice. Xu et al. have elegantly demonstrated
mouse lines has focused the interest of the reproductive a role for Crry in the outcome of murine pregnancy (Xu
immunology community on aspects of innate immunity et al., 2000). Fetal loss is provoked by a deficiency in
that had been largely ignored until now. A flurry of recent Crry, which results in spontaneous complement deposi-
papers have revealed the fundamental role played by tion in the placenta at the fetomaternal interface, and
the innate immune system in spontaneous abortions invasion of the embryos by polymorphonuclear cells.
and, unexpectedly, raise new questions on the interac- Crry-deficient embryos are present on day 9 of gesta-
tion between the adaptive and innate immune systems. tion, but all the embryos die by day 15. Embryonic lethal-
Innate versus Adaptive Immunity during Gestation ity is attributable directly to complement activation,
Although one assumes intuitively that the major cause since all the fetuses survive when Crry-deficient mice are
of abortion may be “immune rejection” of the fetus by intercrossed with C3-deficient mice to produce C3/
the mother, there is no convincing evidence for fetal Crry/ mice.
destruction by the adaptive immune system in a similar It is interesting to note that murine DAF and MCP are
fashion to allogeneic graft rejection (Moffett-King, 2002). not expressed in trophoblasts and early embryos, which
might explain why pregnancy is not affected in mice
deficient in DAF (Xu et al., 2000). Despite the absence*Correspondence: kanellopoulos@ijm.jussieu.fr
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of a human equivalent for Crry, DAF and MCP are ex-
pressed at high levels in human placentas, making it
likely that DAF and MCP may play in human embryonic
development the same role as Crry in mice. In this con-
text, it is interesting to note that some MCP polymor-
phisms in humans are inversely correlated with the inci-
dence of recurrent spontaneous abortions (Risk et al.,
1991), for reasons that were not characterized. Although
DAF polymorphisms in humans have been associated
mainly with paroxysmal nocturnal hemoglobinuria, it is
tempting to speculate that some unexplained recurrent
abortions may be due to loss-of-function mutations in
DAF or MCP.
The importance of the role of complement in pathol-
ogy during pregnancy has been reinforced by the recent
characterization of a mouse model of anti-phospholipid
syndrome (APS) (Holers et al., 2002). This autoimmune
disorder occurs in patients having elevated levels of IgG
antibodies against anionic phospholipid-protein com-
plexes and is characterized by venous or arterial throm-
bosis, resulting in recurrent pregnancy loss. Analysis
of human placentas has shown that trophoblasts are
targeted by the antibodies, and the symptoms of APS
can be reproduced in an animal model by transferring
human anti-phospholipid (aPL) antibodies into pregnant
mice. The aPL antibodies are deposited in the placenta
of the mice and lead to necrosis, fetal loss, or growth
retardation. While most APS models have focused on
the role of thrombosis in the placenta, it was clear that
other proinflammatory factors are also involved, and
the recent study has clearly identified complement as
a culprit.
Injection of aPL into pregnant mice results in antibody
and C3 deposition in the decidua, along with focal necro-
sis and apoptosis and neutrophil infiltration (Holers et
al., 2002). These effects are accompanied by a 4-fold
increase in the frequency of fetal resorption; fetal loss
can be reversed by simultaneous treatment with soluble
recombinant Crry, which also prevents C3 deposition
and neutrophil infiltration. Finally, a causative role for
complement activation was shown conclusively by in-
jecting aPL antibodies into C3-deficient mice, which be-
came resistant to aPL antibody-mediated fetal loss (Hol-
ers et al., 2002). To reevaluate the link between aPL
antibodies and thrombosis, the authors showed that aPL
antibodies induce thrombus formation following local
vascular injury and that soluble Crry significantly de-
creases the size of the thrombi. Thus, complement acti-
vation is likely to be an important upstream mediator in
both aPL IgG-induced vascular thrombosis and fetal loss.
Along similar lines, semi-allogeneic fetuses are re-
sorbed after mothers are treated with an indoleamine
2,-3-dioxygenase (IDO) inhibitor, 1-methyl-tryptophan,
which triggers extensive inflammation, massive comple-
ment deposition (even in the absence of antibodies),
and hemorrhagic necrosis at the fetomaternal interface
(Mellor et al., 2000; Munn et al., 1998), without affecting
Crry expression. Tryptophan is a rare but essential
amino acid required for cell proliferation and is degraded
by IDO, which is expressed especially in antigen-pre-
senting cells of lymphoid organs and in syncytiotropho-
blasts and macrophages during gestation. In vitro, mac-
rophages suppress T cell activity due to degradation of
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tryptophan by IDO, and the suppression is reversed by
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Figure 1. Crry Deletion, or Treatment with
Anti-Phospholipid Antibodies or IDO Inhibi-
tor, Leads to C3 Deposition and Abortion
The effector mechanisms responsible for
abortion in TBPN/N mice remain to be
characterized. Mouse pregnancy on day 8
postcoitum. Abbreviations: d, maternal de-
cidua; gc, trophoblast giant cells; ec, ectopla-
cental cone; ep, embryo proper.
treatment with an IDO inhibitor (Munn et al., 1999). A infused into mothers, to rule out the possibility that the
inhibitor may be having effects through by-products ofrole for IDO during pregnancy was suggested by the
observation that the tryptophan concentration is signifi- the IDO reaction (Bonney and Matzinger, 1998).
From Transcriptional Dysregulation to Abortioncantly lower in pregnant women than in nonpregnant
controls. It was therefore proposed that IDO activity More recently, a fascinating case of serendipity led to
the discovery that the deletion of the N-terminal domainmay protect the fetus by suppressing T cell-dependent
inflammatory responses to fetal alloantigens. In favor (N) of TBP (TATA binding protein, ubiquitously used
for promoter recognition during transcription initiationof this view, fetuses are not rejected and there is no
complement C3 deposition nor T cell infiltration after by RNA polymerases) does not affect early development
nor organogenesis but results in a placental alterationtreatment of syngeneic mothers with IDO inhibitor, and
semi-allogeneic fetuses are protected in RAG-1/ that triggers inflammation, hemorrhaging, and clotting,
such that over 90% of homozygous TBPN/N fetusesmothers exposed to the inhibitor (Mellor et al., 2000;
Munn et al., 1998). T cells mediate the effects and B die in midgestation (Hobbs et al., 2002). A potential role
for C3 activation and deposition in these abortions wascells are not required, since fetuses are lost in treated
RAG-1/ mothers carrying monoclonal CD8 T cells not investigated. However, the few remaining TBPN/
N animals that survive beyond weaning are perfectlyspecific for a single MHC class I antigen inherited from
the father. Thus, trophoblasts and antigen-presenting healthy and fertile adults.
Curiously, the local placental damage was avertedcells in the placenta may protect the fetus via tryptophan
catabolism, thus preventing a unique type of inflamma- in most mutant fetuses by rearing them in RAG-1/-
deficient mothers. Moreover, about half of the 2-micro-tion that involves alloreactive T cell-dependent, anti-
body-independent complement activation. globulin (2m)/ TBPN/N fetuses were protected in
immunocompetent RAG-1/ mothers. Thus, the au-These studies demonstrate unambiguously that fetal
allo-recognition by the immune system can lead to com- thors hypothesize that the TBPN deletion may lead to
placental expression of MHC class I molecules or, moreplement activation and that the absence of complement
regulatory proteins leads to fetal lethality, even in fully likely, nonclassical “class I-like” 2m-dependent mole-
cules that may trigger a local, maternal innate immunehistocompatible pregnancies.
But it still remains to be determined which T cell- response. They propose that the main function of the
TBP N terminus may be to either downregulate placentaldependent pathways in the placenta lead to comple-
ment activation in the absence of antibodies. In addition, expression of 2m or the MHC class I or class I-like
heavy chain, or to allow the expression of a negativeother mechanisms that allow IDO to suppress maternal
T cell responses were not elucidated in the original pa- regulator that in turn prevents class I expression. How-
ever, the abortions occurred in the absence of identifiedpers, as IDO not only depletes tryptophan concentrations
but also produces compounds such as N-formylkynure- major or minor histocompatibility differences and pre-
sented no evidence of maternal immunological memory.nine through a reaction that removes oxygen radicals
from the environment (Bonney and Matzinger, 1998). It is thus tempting to invoke a role for V11 T cells or
V14 NKT cells, which are involved in fetal resorptionsThus, IDO inhibition could also, among other effects,
increase the amount of reactive oxygen species, which (Dang and Heyborne, 2001; Ito et al., 2000; Yamasaki et
al., 2001). These NKT cells are more abundant in thewould stimulate macrophages in the placenta (Bonney
and Matzinger, 1998). Presentation of fetal antigens by human decidua than in peripheral blood, and their li-
gand, the nonclassical MHC molecule CD1d, is presentthese activated macrophages could perhaps account
for the observation that IDO inhibition results in demise on human trophoblasts (Boyson et al., 2002), although
an interaction between NKT cells and CD1d in the pla-of allogeneic but not syngeneic fetuses. Other alterna-
tive mechanisms are suggested by an analysis of the centa has yet to be demonstrated. NKT cells would be
absent in RAG-1/ mothers and their differential devel-biological effects of the products from the IDO reaction.
Kynurerine, 3-hydroxykynurenine, and 3-hydroxyanthrani- opment within each placenta could explain why geneti-
cally similar fetuses have a different fate within the samelic acids suppress T cell responses irreversibly due to
T cell death, although B and natural killer (NK) cells are uterus. Moreover, MHC class I-related molecules asso-
ciated with 2m are involved in a myriad of functionsalso killed (Terness et al., 2002). A worthwhile suggestion
has been made by Bonney and Matzinger, who propose beyond their traditional role in antigen-presentation and
signaling to NK cells, including transcytosis of immuno-that tryptophan, rather than the IDO inhibitor, should be
Immunity
172
Boyson, J.E., Rybalov, B., Koopman, L.A., Exley, M., Balk, S.P.,globulins, modulation of transferrin receptor endocyto-
Racke, F.K., Schatz, F., Masch, R., Wilson, S.B., and Strominger,sis, and development of the central nervous system (Oj-
J.L. (2002). CD1d and invariant NKT cells at the human maternal-cius et al., 2002). It is thus conceivable that a nonimmune
fetal interface. Proc. Natl. Acad. Sci. USA 99, 13741–13746.
mechanism may affect trophoblast development or dis-
Dang, Y., and Heyborne, K.D. (2001). Cutting edge: regulation of
rupt an essential placental function in the TBPN/N uterine NKT cells by a fetal class I molecule other than CD1. J.
mice, either directly or, given the other precedents de- Immunol. 166, 3641–3644.
scribed above, via complement activation. Hobbs, N.K., Bondareva, A.A., Barnett, S., Capecchi, M.R., and
Common Traits and Missing Links Schmidt, E.E. (2002). Removing the vertebrate-specific TBP N termi-
The most prominent features of the different experimen- nus disrupts placental 2m-dependent interactions with the mater-
nal immune system. Cell 110, 43–54.tal systems leading to abortion are summarized in Table
Holers, V.M., Girardi, G., Mo, L., Guthridge, J.M., Molina, H., Pier-1 and Figure 1. The most striking observation is the
angeli, S.S., Espinola, R., Xiaowei, L.E., Mao, D., Vialpando, C.G.,remarkable similarity in the end-point mechanisms in-
and Salmon, J.E. (2002). Complement C3 activation is required forvolved in the destruction of the feto-placental unit. All
antiphospholipid antibody-induced fetal loss. J. Exp. Med. 195,of them appear to be localized at the fetomaternal inter-
211–220.
face, within the placenta or involving both the tropho-
Ito, K., Karasawa, M., Kawana, T., Akasaka, T., Koseki, H., Akutsu,
blast and decidua, i.e., the fetal and maternal sides, Y., Kondo, E., Sekiya, S., Sekikawa, K., Harada, M., et al. (2000).
respectively. And when characterized, all of them in- Involvement of decidual V14 NKT cells in abortion. Proc. Natl.
clude local C3 activation and deposition, and inflamma- Acad. Sci. USA 97, 740–744.
tion as well as inflammatory cell infiltration that may be Jiang, S.P., and Vacchio, M.S. (1998). Multiple mechanisms of pe-
ripheral T cell tolerance to the fetal “allograft”. J. Immunol. 160,a by-product of complement activation. Although the
3086–3090.mechanisms are similar, the time courses differ, as treat-
Medawar, P.B. (1953). Some immunological and endocrinologicalment with IDO inhibitor triggers earlier resorption and
problems raised by the evolution of viviparity in vertebrates. Symp.hemorrhaging than in the other systems. But the final
Soc. Exp. Biol. 11, 320–338.outcome is the same and leads to demise of essentially
Mellor, A.L., Sivakumar, J., Chandler, P., Smith, K., Molina, H., Mao,all fetuses, except that some aPL-treated fetuses sur-
D., and Munn, D.H. (2000). Prevention of T cell-driven complementvive, displaying only growth retardation, and a minority
activation and inflammation by tryptophan catabolism during preg-
of TBPN/N fetuses are protected in a stochastic man- nancy. Nat. Immunol. 2, 64–68.
ner that still lacks a satisfactory explanation. It also Moffett-King, A. (2002). Natural killer cells and pregnancy. Nat. Rev.
remains to be seen whether complement activation and, Immunol. 2, 656–663.
in particular, C3 deposition may play a role in the abor- Morgan, B.P., and Holmes, C.H. (2000). Immunology of reproduction:
tion of TBPN/N fetuses. Whether C3 deposition is a protecting the placenta. Curr. Biol. 10, R381–R383.
cause or a consequence of fetal damage in the IDO Munn, D.H., Zhou, M., Attwood, J.T., Bondarev, I., Conway, S.J.,
system remains an open question. For the other two Marshall, B., Brown, C., and Mellor, A.L. (1998). Prevention of alloge-
neic fetal rejection by tryptophan catabolism. Science 281, 1191–experimental systems, complement activation appears
1193.to be a primary cause of fetal demise, since Crry-defi-
Munn, D.H., Shafizadeh, E., Attwood, J.T., Bondarev, I., Pashine, A.,cient mothers produce healthy fetuses when they are
and Mellor, A.L. (1999). Inhibition of T cell proliferation by macro-intercrossed with C3-deficient mice and no fetal injury
phage tryptophan catabolism. J. Exp. Med. 189, 1363–1372.is observed when C3-deficient mothers are injected with
Ojcius, D.M., Delarbre, C., Kourilsky, P., and Gachelin, G. (2002).aPL antibodies.
MHC and MHC-related proteins as pleiotropic signal molecules.
Interestingly, the missing link in all systems concerns FASEB J. 16, 202–206.
the identification of the local effector cells and, when
Risk, J.M., Flanagan, B.F., and Johnson, P.M. (1991). Polymorphism
relevant, their antigen specificity, as well as the mecha- of the human CD46 gene in normal individuals and in recurrent
nisms bridging antigen recognition by the adaptive sys- spontaneous abortion. Hum. Immunol. 30, 162–167.
tem and triggering of innate immune effectors. Although Terness, P., Bauer, T.M., Rose, L., Dufter, C., Watzlik, A., Simon, H.,
the precise cellular and molecular pathways remain to and Opelz, G. (2002). Inhibition of allogeneic T cell proliferation by
indoleamine 2,3-dioxygenase-expressing dendritic cells: mediationbe characterized, it is remarkable that the destruction
of suppression by tryptophan metabolites. J. Exp. Med. 196,of the feto-placental units by local innate mechanisms
447–457.is prevented in mothers lacking a functional adaptive
Xu, C., Mao, D., Holers, V.M., Palanca, B., Cheng, A.M., and Molina,immune system. The classical scheme of immune re-
H. (2000). A critical role for murine complement regulator crry insponses involves innate responses occurring first and
fetomaternal tolerance. Science 287, 498–501.
contributing subsequently to the development of adap-
Yamasaki, M., Sasho, T., Moriya, H., Kanno, M., Harada, M., Kamada,tive responses. Intriguingly, the current state of knowl- N., Shimizu, E., Nakayama, T., and Taniguchi, M. (2001). Extrathymic
edge on fetomaternal interactions suggests a reversal development of V11 T cells in placenta during pregnancy and their
of roles, where innate immune responses are triggered possible physiological role. J. Immunol. 166, 7244–7249.
by components of the adaptive system.
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